BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo CH, Noh SH, Kim YI, Min JS. Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. International Union Against Cancer. World J Surg. 1999;23:492-47; discussion 492-47;. [PMID: 10085399 DOI: 10.1007/pl00012337] [Cited by in Crossref: 54] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim SH, Ha TK, Kwon SJ. Evaluation of the 7th AJCC TNM Staging System in Point of Lymph Node Classification. J Gastric Cancer. 2011;11:94-100. [PMID: 22076209 DOI: 10.5230/jgc.2011.11.2.94] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jin ML, Gong Y, Pei YC, Ji P, Hu X, Shao ZM. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems. Breast 2020;49:93-100. [PMID: 31783315 DOI: 10.1016/j.breast.2019.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xiao LB, Yu JX, Wu WH, Xu FF, Yang SB. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 2011; 17(46): 5123-5130 [PMID: 22171148 DOI: 10.3748/wjg.v17.i46.5123] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
4 Catarci M, Montemurro LA, Ghinassi S, Di Cintio A, Leone L, Cosentino LM, Viarengo MA, Grassi GB. Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer. Updates Surg. 2011;63:83-90. [PMID: 21445644 DOI: 10.1007/s13304-011-0065-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Liu CG, Lu P, Lu Y, Jin F, Xu HM, Wang SB, Chen JQ. Distribution of solitary lymph nodes in primary gastric cancer: A retrospective study and clinical implications. World J Gastroenterol 2007; 13(35): 4776-4780 [PMID: 17729400 DOI: 10.3748/wjg.v13.i35.4776] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
6 Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH, Rha SY. Prognosis of pN3 stage gastric cancer. Cancer Res Treat 2009;41:73-9. [PMID: 19707504 DOI: 10.4143/crt.2009.41.2.73] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
7 de Manzoni G, Verlato G, Roviello F, Morgagni P, Di Leo A, Saragoni L, Marrelli D, Kurihara H, Pasini F. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 2002;87:171-4. [PMID: 12107838 DOI: 10.1038/sj.bjc.6600432] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 3.5] [Reference Citation Analysis]
8 Zhang CW, Zou SC, Shi D, Zhao DJ. Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer. World J Gastroenterol 2004; 10(20): 3070-3072 [PMID: 15378797 DOI: 10.3748/wjg.v10.i20.3070] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
9 Lee CC, Ho HC, Su YC, Lee MS, Hung SK, Chen YL. The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell Carcinoma. Medicine (Baltimore) 2015;94:e1069. [PMID: 26166079 DOI: 10.1097/MD.0000000000001069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
10 Hyung WJ, Kim SS, Choi WH, Cheong JH, Choi SH, Kim CB, Noh SH. Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution. Yonsei Med J. 2008;49:409-415. [PMID: 18581590 DOI: 10.3349/ymj.2008.49.3.409] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
11 Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol 2011; 17(27): 3257-3262 [PMID: 21912476 DOI: 10.3748/wjg.v17.i27.3257] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
12 Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, Kikuchi H, Kagaya T. Alternating treatment with S-1 plus low-dose cisplatin and S-1 alone for advanced gastric cancer. J Gastrointest Surg 2011;15:791-6. [PMID: 21512899 DOI: 10.1007/s11605-011-1476-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Lin Y, Wang X, Yu Y, Liu W, Xie F, Ouyang X, Huang Q. Expression and prognostic significance of cyclin-dependent kinase inhibitor 1A in patients with resected gastric adenocarcinoma. Oncol Lett 2017;14:7473-82. [PMID: 29344191 DOI: 10.3892/ol.2017.7107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Qiu MZ, Qiu HJ, Wang ZQ, Ren C, Wang DS, Zhang DS, Luo HY, Li YH, Xu RH. The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China. PLoS One. 2012;7:e31736. [PMID: 22348125 DOI: 10.1371/journal.pone.0031736] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
15 Park JM, Kim JH, Park SS, Kim SJ, Mok YJ, Kim CS. Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II. World J Surg. 2008;32:1037-1044. [PMID: 18347851 DOI: 10.1007/s00268-007-9440-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]